Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
Human tibia bone marrow blood perfusion by non-invasive near infrared spectroscopy: a new tool for studies on microgravity.

Journal of gravitational physiology : a journal of the International Society for Gravitational Physiology

Binzoni T, Blanchi S, Fasel JH, Bounameaux H, Hiltbrand E, Delpy D.
PMID: 15002539
J Gravit Physiol. 2002 Jul;9(1):P183-4.

Human tibia bone marrow (BM) and tibialis anterior muscle (TA) perfusion index (PI) was assessed non-invasively by near infrared spectroscopy. A decrease in the postis-chaemic reperfusion capability of the human tibia BM and TA muscle was observed for increasing...

Cite
Binzoni T, Blanchi S, Fasel JH, et al. Human tibia bone marrow blood perfusion by non-invasive near infrared spectroscopy: a new tool for studies on microgravity. J Gravit Physiol. 2002;9(1):P183-4
Binzoni, T., Blanchi, S., Fasel, J. H., Bounameaux, H., Hiltbrand, E., & Delpy, D. (2002). Human tibia bone marrow blood perfusion by non-invasive near infrared spectroscopy: a new tool for studies on microgravity. Journal of gravitational physiology : a journal of the International Society for Gravitational Physiology, 9(1), P183-4.
Binzoni, T, et al. "Human tibia bone marrow blood perfusion by non-invasive near infrared spectroscopy: a new tool for studies on microgravity." Journal of gravitational physiology : a journal of the International Society for Gravitational Physiology vol. 9,1 (2002): P183-4.
Binzoni T, Blanchi S, Fasel JH, Bounameaux H, Hiltbrand E, Delpy D. Human tibia bone marrow blood perfusion by non-invasive near infrared spectroscopy: a new tool for studies on microgravity. J Gravit Physiol. 2002 Jul;9(1):P183-4. PMID: 15002539.
Copy Download .nbib Format: NLM
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies.

Thrombosis journal

Prins MH, Lensing AW, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Raskob GE, Berkowitz SD, Wells PS.
PMID: 24053656
Thromb J. 2013 Sep 20;11(1):21. doi: 10.1186/1477-9560-11-21.

BACKGROUND: Standard treatment for venous thromboembolism (VTE) consists of a heparin combined with vitamin K antagonists. Direct oral anticoagulants have been investigated for acute and extended treatment of symptomatic VTE; their use could avoid parenteral treatment and/or laboratory monitoring...

Cite
Prins MH, Lensing AW, Bauersachs R, et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J. 2013;11(1):21doi: 10.1186/1477-9560-11-21.
Prins, M. H., Lensing, A. W., Bauersachs, R., van Bellen, B., Bounameaux, H., Brighton, T. A., Cohen, A. T., Davidson, B. L., Decousus, H., Raskob, G. E., Berkowitz, S. D., Wells, P. S. (2013). Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thrombosis journal, 11(1), 21. https://doi.org/10.1186/1477-9560-11-21
Prins, Martin H, et al. "Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies." Thrombosis journal vol. 11,1 (2013): 21. doi: https://doi.org/10.1186/1477-9560-11-21
Prins MH, Lensing AW, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Raskob GE, Berkowitz SD, Wells PS. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J. 2013 Sep 20;11(1):21. doi: 10.1186/1477-9560-11-21. PMID: 24053656; PMCID: PMC3850944.
Copy Download .nbib Format: NLM
Costs of Implementing an Integrated Package of Maternal and Pediatric Interventions Including SQ-LNS in Rural Niger.

Food and nutrition bulletin

Hiebert L, Phelan K, Kinda M, Dan-Bouzoua N, Kyungu M, Bounameaux T, Sayadi S, Maidadji O, Hecht R.
PMID: 34467822
Food Nutr Bull. 2021 Dec;42(4):567-583. doi: 10.1177/03795721211039869. Epub 2021 Sep 01.

BACKGROUND: In January 2015, the Alliance for International Medical Action and Bien Être de la Femme et de l'Enfant au Niger launched the 1000 Days Program in Mirriah District, Niger, to provide an integrated package of maternal and pediatric...

Cite
Hiebert L, Phelan K, Kinda M, et al. Costs of Implementing an Integrated Package of Maternal and Pediatric Interventions Including SQ-LNS in Rural Niger. Food Nutr Bull. 2021;42(4):567-583doi: 10.1177/03795721211039869.
Hiebert, L., Phelan, K., Kinda, M., Dan-Bouzoua, N., Kyungu, M., Bounameaux, T., Sayadi, S., Maidadji, O., & Hecht, R. (2021). Costs of Implementing an Integrated Package of Maternal and Pediatric Interventions Including SQ-LNS in Rural Niger. Food and nutrition bulletin, 42(4), 567-583. https://doi.org/10.1177/03795721211039869
Hiebert, Lindsey, et al. "Costs of Implementing an Integrated Package of Maternal and Pediatric Interventions Including SQ-LNS in Rural Niger." Food and nutrition bulletin vol. 42,4 (2021): 567-583. doi: https://doi.org/10.1177/03795721211039869
Hiebert L, Phelan K, Kinda M, Dan-Bouzoua N, Kyungu M, Bounameaux T, Sayadi S, Maidadji O, Hecht R. Costs of Implementing an Integrated Package of Maternal and Pediatric Interventions Including SQ-LNS in Rural Niger. Food Nutr Bull. 2021 Dec;42(4):567-583. doi: 10.1177/03795721211039869. Epub 2021 Sep 01. PMID: 34467822.
Copy Download .nbib Format: NLM
Implementing thrombosis guidelines in cancer patients: a review.

Rambam Maimonides medical journal

Farge-Bancel D, Bounameaux H, Brenner B, Büller HR, Kakkar A, Pabinger I, Streiff M, Debourdeau P.
PMID: 25386357
Rambam Maimonides Med J. 2014 Oct 29;5(4):e0041. doi: 10.5041/RMMJ.10175. eCollection 2014 Oct.

Venous thromboembolism is a frequent and serious complication in patients with cancer. It is an independent prognostic factor of death in cancer patients and the second leading cause of death, but physicians often underestimate its importance, as well as...

Cite
Farge-Bancel D, Bounameaux H, Brenner B, et al. Implementing thrombosis guidelines in cancer patients: a review. Rambam Maimonides Med J. 2014;5(4):e0041doi: 10.5041/RMMJ.10175.
Farge-Bancel, D., Bounameaux, H., Brenner, B., Büller, H. R., Kakkar, A., Pabinger, I., Streiff, M., & Debourdeau, P. (2014). Implementing thrombosis guidelines in cancer patients: a review. Rambam Maimonides medical journal, 5(4), e0041. https://doi.org/10.5041/RMMJ.10175
Farge-Bancel, Dominique, et al. "Implementing thrombosis guidelines in cancer patients: a review." Rambam Maimonides medical journal vol. 5,4 (2014): e0041. doi: https://doi.org/10.5041/RMMJ.10175
Farge-Bancel D, Bounameaux H, Brenner B, Büller HR, Kakkar A, Pabinger I, Streiff M, Debourdeau P. Implementing thrombosis guidelines in cancer patients: a review. Rambam Maimonides Med J. 2014 Oct 29;5(4):e0041. doi: 10.5041/RMMJ.10175. eCollection 2014 Oct. PMID: 25386357; PMCID: PMC4222430.
Copy Download .nbib Format: NLM
ACP Journal Club. Ultrasonography-guided oral anticoagulant therapy reduced recurrent venous thromboembolism.

Annals of internal medicine

Bounameaux H.
PMID: 19755355
Ann Intern Med. 2009 Sep 15;151(6):JC3-9. doi: 10.7326/0003-4819-151-6-200909150-02009.

No abstract available.

Cite
Bounameaux H. ACP Journal Club. Ultrasonography-guided oral anticoagulant therapy reduced recurrent venous thromboembolism. Ann Intern Med. 2009;151(6):JC3-9doi: 10.7326/0003-4819-151-6-200909150-02009.
Bounameaux, H. (2009). ACP Journal Club. Ultrasonography-guided oral anticoagulant therapy reduced recurrent venous thromboembolism. Annals of internal medicine, 151(6), JC3-9. https://doi.org/10.7326/0003-4819-151-6-200909150-02009
Bounameaux, Henri. "ACP Journal Club. Ultrasonography-guided oral anticoagulant therapy reduced recurrent venous thromboembolism." Annals of internal medicine vol. 151,6 (2009): JC3-9. doi: https://doi.org/10.7326/0003-4819-151-6-200909150-02009
Bounameaux H. ACP Journal Club. Ultrasonography-guided oral anticoagulant therapy reduced recurrent venous thromboembolism. Ann Intern Med. 2009 Sep 15;151(6):JC3-9. doi: 10.7326/0003-4819-151-6-200909150-02009. PMID: 19755355.
Copy Download .nbib Format: NLM
Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report.

Chest

Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores LK.
PMID: 34352278
Chest. 2021 Dec;160(6):e545-e608. doi: 10.1016/j.chest.2021.07.055. Epub 2021 Aug 02.

BACKGROUND: This is the 2nd update to the 9th edition of these guidelines. We provide recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions, four of which have not been addressed previously.METHODS: We generate strong and weak recommendations based...

Cite
Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):e545-e608doi: 10.1016/j.chest.2021.07.055.
Stevens, S. M., Woller, S. C., Kreuziger, L. B., Bounameaux, H., Doerschug, K., Geersing, G. J., Huisman, M. V., Kearon, C., King, C. S., Knighton, A. J., Lake, E., Murin, S., Vintch, J. R. E., Wells, P. S., & Moores, L. K. (2021). Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest, 160(6), e545-e608. https://doi.org/10.1016/j.chest.2021.07.055
Stevens, Scott M, et al. "Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report." Chest vol. 160,6 (2021): e545-e608. doi: https://doi.org/10.1016/j.chest.2021.07.055
Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores LK. Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest. 2021 Dec;160(6):e545-e608. doi: 10.1016/j.chest.2021.07.055. Epub 2021 Aug 02. PMID: 34352278.
Copy Download .nbib Format: NLM
Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE.

Journal of thrombosis and haemostasis : JTH

Weitz JI, Farjat AE, Ageno W, Turpie AGG, Haas S, Goto S, Goldhaber SZ, Angchaisuksiri P, Gibbs H, MacCallum P, Carrier M, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK.
PMID: 34487616
J Thromb Haemost. 2021 Dec;19(12):3031-3043. doi: 10.1111/jth.15520. Epub 2021 Sep 16.

BACKGROUND: There is limited information on the influence of body mass index (BMI) on clinical outcomes in patients with venous thromboembolism (VTE).OBJECTIVES: Investigate the influence of BMI on baseline characteristics, treatment patterns, and 24-month outcomes in VTE patients.METHODS: GARFIELD-VTE...

Cite
Weitz JI, Farjat AE, Ageno W, et al. Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE. J Thromb Haemost. 2021;19(12):3031-3043doi: 10.1111/jth.15520.
Weitz, J. I., Farjat, A. E., Ageno, W., Turpie, A. G. G., Haas, S., Goto, S., Goldhaber, S. Z., Angchaisuksiri, P., Gibbs, H., MacCallum, P., Carrier, M., Kayani, G., Schellong, S., Bounameaux, H., Mantovani, L. G., Prandoni, P., Kakkar, A. K. (2021). Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE. Journal of thrombosis and haemostasis : JTH, 19(12), 3031-3043. https://doi.org/10.1111/jth.15520
Weitz, Jeffrey I, et al. "Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE." Journal of thrombosis and haemostasis : JTH vol. 19,12 (2021): 3031-3043. doi: https://doi.org/10.1111/jth.15520
Weitz JI, Farjat AE, Ageno W, Turpie AGG, Haas S, Goto S, Goldhaber SZ, Angchaisuksiri P, Gibbs H, MacCallum P, Carrier M, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK. Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE. J Thromb Haemost. 2021 Dec;19(12):3031-3043. doi: 10.1111/jth.15520. Epub 2021 Sep 16. PMID: 34487616.
Copy Download .nbib Format: NLM
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE.

TH open : companion journal to thrombosis and haemostasis

Jerjes-Sánchez C, Rodriguez D, Farjat AE, Kayani G, MacCallum P, Lopes RD, Turpie AGG, Weitz JI, Haas S, Ageno W, Goto S, Goldhaber SZ, Angchaisuksiri P, Nielsen JD, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK.
PMID: 33532693
TH Open. 2021 Jan 27;5(1):e24-e34. doi: 10.1055/s-0040-1722611. eCollection 2021 Jan.

No abstract available.

Cite
Jerjes-Sánchez C, Rodriguez D, Farjat AE, et al. Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE. TH Open. 2021;5(1):e24-e34doi: 10.1055/s-0040-1722611.
Jerjes-Sánchez, C., Rodriguez, D., Farjat, A. E., Kayani, G., MacCallum, P., Lopes, R. D., Turpie, A. G. G., Weitz, J. I., Haas, S., Ageno, W., Goto, S., Goldhaber, S. Z., Angchaisuksiri, P., Nielsen, J. D., Schellong, S., Bounameaux, H., Mantovani, L. G., Prandoni, P., Kakkar, A. K. (2021). Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE. TH open : companion journal to thrombosis and haemostasis, 5(1), e24-e34. https://doi.org/10.1055/s-0040-1722611
Jerjes-Sánchez, Carlos, et al. "Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE." TH open : companion journal to thrombosis and haemostasis vol. 5,1 (2021): e24-e34. doi: https://doi.org/10.1055/s-0040-1722611
Jerjes-Sánchez C, Rodriguez D, Farjat AE, Kayani G, MacCallum P, Lopes RD, Turpie AGG, Weitz JI, Haas S, Ageno W, Goto S, Goldhaber SZ, Angchaisuksiri P, Nielsen JD, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK. Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE. TH Open. 2021 Jan 27;5(1):e24-e34. doi: 10.1055/s-0040-1722611. eCollection 2021 Jan. PMID: 33532693; PMCID: PMC7840428.
Copy Download .nbib Format: NLM
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE.

Research and practice in thrombosis and haemostasis

Ageno W, Farjat A, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK.
PMID: 33733032
Res Pract Thromb Haemost. 2021 Feb 20;5(2):326-341. doi: 10.1002/rth2.12482. eCollection 2021 Feb.

INTRODUCTION: Venous thromboembolism (VTE) has a long-term risk of recurrence, dependent on the presence or absence of provoking risk factors at the time of the event.OBJECTIVE: To compare clinical characteristics, anticoagulant patterns, and 12-month outcomes in patients with transient...

Cite
Ageno W, Farjat A, Haas S, et al. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE. Res Pract Thromb Haemost. 2021;5(2):326-341doi: 10.1002/rth2.12482.
Ageno, W., Farjat, A., Haas, S., Weitz, J. I., Goldhaber, S. Z., Turpie, A. G. G., Goto, S., Angchaisuksiri, P., Dalsgaard Nielsen, J., Kayani, G., Schellong, S., Bounameaux, H., Mantovani, L. G., Prandoni, P., & Kakkar, A. K. (2021). Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE. Research and practice in thrombosis and haemostasis, 5(2), 326-341. https://doi.org/10.1002/rth2.12482
Ageno, Walter, et al. "Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE." Research and practice in thrombosis and haemostasis vol. 5,2 (2021): 326-341. doi: https://doi.org/10.1002/rth2.12482
Ageno W, Farjat A, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE. Res Pract Thromb Haemost. 2021 Feb 20;5(2):326-341. doi: 10.1002/rth2.12482. eCollection 2021 Feb. PMID: 33733032; PMCID: PMC7938631.
Copy Download .nbib Format: NLM
Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112].

Thrombosis research

Bounameaux H, Haas S, Farjat AE, Ageno W, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Schellong S, Mantovani LG, Prandoni P, Kakkar AK.
PMID: 34863582
Thromb Res. 2021 Dec 01; doi: 10.1016/j.thromres.2021.11.023. Epub 2021 Dec 01.

No abstract available.

Cite
Bounameaux H, Haas S, Farjat AE, et al. Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112]. Thromb Res. 2021;doi: 10.1016/j.thromres.2021.11.023.
Bounameaux, H., Haas, S., Farjat, A. E., Ageno, W., Weitz, J. I., Goldhaber, S. Z., Turpie, A. G. G., Goto, S., Angchaisuksiri, P., Nielsen, J. D., Kayani, G., Schellong, S., Mantovani, L. G., Prandoni, P., & Kakkar, A. K. (2021). Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112]. Thrombosis research, . https://doi.org/10.1016/j.thromres.2021.11.023
Bounameaux, Henri, et al. "Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112]." Thrombosis research vol. (2021). doi: https://doi.org/10.1016/j.thromres.2021.11.023
Bounameaux H, Haas S, Farjat AE, Ageno W, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Schellong S, Mantovani LG, Prandoni P, Kakkar AK. Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112]. Thromb Res. 2021 Dec 01; doi: 10.1016/j.thromres.2021.11.023. Epub 2021 Dec 01. PMID: 34863582.
Copy Download .nbib Format: NLM
The role of the D-dimer in the diagnosis of venous thromboembolism.

Seminars in respiratory and critical care medicine

Ahearn GS, Bounameaux H.
PMID: 16088761
Semin Respir Crit Care Med. 2000;21(6):521-36. doi: 10.1055/s-2000-13186.

Classic enzyme-linked immunosorbent assay (ELISA) D-dimer assays are sensitive in screening for thromboembolic disease; however, they are cumbersome and time consuming to perform, which limits their routine use. Latex agglutination assays are easier to perform, but they are not...

Cite
Ahearn GS, Bounameaux H. The role of the D-dimer in the diagnosis of venous thromboembolism. Semin Respir Crit Care Med. 2000;21(6):521-36doi: 10.1055/s-2000-13186.
Ahearn, G. S., & Bounameaux, H. (2000). The role of the D-dimer in the diagnosis of venous thromboembolism. Seminars in respiratory and critical care medicine, 21(6), 521-36. https://doi.org/10.1055/s-2000-13186
Ahearn, G S, and Bounameaux, H. "The role of the D-dimer in the diagnosis of venous thromboembolism." Seminars in respiratory and critical care medicine vol. 21,6 (2000): 521-36. doi: https://doi.org/10.1055/s-2000-13186
Ahearn GS, Bounameaux H. The role of the D-dimer in the diagnosis of venous thromboembolism. Semin Respir Crit Care Med. 2000;21(6):521-36. doi: 10.1055/s-2000-13186. PMID: 16088761.
Copy Download .nbib Format: NLM
Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper.

Open heart

Abraham P, Arroyo DA, Giraud R, Bounameaux H, Bendjelid K.
PMID: 29531763
Open Heart. 2018 Feb 26;5(1):e000735. doi: 10.1136/openhrt-2017-000735. eCollection 2018.

While systemic intravenous thrombolysis decreases mortality in patients with high-risk pulmonary embolism (PE), it clearly increases haemorrhagic risk. There are many contraindications to thrombolysis, and efforts should aim at selecting those patients who will benefit most, without suffering complications....

Cite
Abraham P, Arroyo DA, Giraud R, et al. Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper. Open Heart. 2018;5(1):e000735doi: 10.1136/openhrt-2017-000735.
Abraham, P., Arroyo, D. A., Giraud, R., Bounameaux, H., & Bendjelid, K. (2018). Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper. Open heart, 5(1), e000735. https://doi.org/10.1136/openhrt-2017-000735
Abraham, Paul, et al. "Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper." Open heart vol. 5,1 (2018): e000735. doi: https://doi.org/10.1136/openhrt-2017-000735
Abraham P, Arroyo DA, Giraud R, Bounameaux H, Bendjelid K. Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper. Open Heart. 2018 Feb 26;5(1):e000735. doi: 10.1136/openhrt-2017-000735. eCollection 2018. PMID: 29531763; PMCID: PMC5845427.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries